Suppr超能文献

心肌内注射水凝胶对心肌梗死后左心室重塑产生积极影响的时间效应。

Timing effect of intramyocardial hydrogel injection for positively impacting left ventricular remodeling after myocardial infarction.

作者信息

Yoshizumi Tomo, Zhu Yang, Jiang Hongbin, D'Amore Antonio, Sakaguchi Hirokazu, Tchao Jason, Tobita Kimimasa, Wagner William R

机构信息

McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 15219, USA.

McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 15219, USA; Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15219, USA.

出版信息

Biomaterials. 2016 Mar;83:182-93. doi: 10.1016/j.biomaterials.2015.12.002. Epub 2015 Dec 15.

Abstract

Intramyocardial injection of various injectable hydrogel materials has shown benefit in positively impacting the course of left ventricular (LV) remodeling after myocardial infarction (MI). However, since LV remodeling is a complex, time dependent process, the most efficacious time of hydrogel injection is not clear. In this study, we injected a relatively stiff, thermoresponsive and bioabsorbable hydrogel in rat hearts at 3 different time points - immediately after MI (IM), 3 d post-MI (3D), and 2 w post-MI (2W), corresponding to the beginnings of the necrotic, fibrotic and chronic remodeling phases. The employed left anterior descending coronary artery ligation model showed expected infarction responses including functional loss, inflammation and fibrosis with distinct time dependent patterns. Changes in LV geometry and contractile function were followed by longitudinal echocardiography for 10 w post-MI. While all injection times positively affected LV function and wall thickness, the 3D group gave better functional outcomes than the other injection times and also exhibited more local vascularization and less inflammatory markers than the earlier injection time. The results indicate an important role for injection timing in the increasingly explored concept of post-MI biomaterial injection therapy and suggest that for hydrogels with mechanical support as primary function, injection at the beginning of the fibrotic phase may provide improved outcomes.

摘要

心肌内注射各种可注射水凝胶材料已显示出对心肌梗死(MI)后左心室(LV)重塑过程产生积极影响的益处。然而,由于左心室重塑是一个复杂的、随时间变化的过程,水凝胶注射的最有效时间尚不清楚。在本研究中,我们在大鼠心脏的3个不同时间点注射了一种相对坚硬、热响应性和生物可吸收的水凝胶——心肌梗死后立即注射(IM)、心肌梗死后3天(3D)和心肌梗死后2周(2W),分别对应坏死、纤维化和慢性重塑阶段的开始。所采用的左冠状动脉前降支结扎模型显示出预期的梗死反应,包括功能丧失、炎症和纤维化,具有明显的时间依赖性模式。在心肌梗死后10周通过纵向超声心动图跟踪左心室几何形状和收缩功能的变化。虽然所有注射时间都对左心室功能和壁厚度产生了积极影响,但3D组的功能结果优于其他注射时间,并且与早期注射时间相比,还表现出更多的局部血管化和更少的炎症标志物。结果表明注射时间在越来越受关注的心肌梗死后生物材料注射治疗概念中起着重要作用,并表明对于以机械支撑为主要功能的水凝胶,在纤维化阶段开始时注射可能会提供更好的结果。

相似文献

1
Timing effect of intramyocardial hydrogel injection for positively impacting left ventricular remodeling after myocardial infarction.
Biomaterials. 2016 Mar;83:182-93. doi: 10.1016/j.biomaterials.2015.12.002. Epub 2015 Dec 15.
2
MRI evaluation of injectable hyaluronic acid-based hydrogel therapy to limit ventricular remodeling after myocardial infarction.
Biomaterials. 2015 Nov;69:65-75. doi: 10.1016/j.biomaterials.2015.08.011. Epub 2015 Aug 6.
3
Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodeling.
Am J Physiol Heart Circ Physiol. 2018 Oct 1;315(4):H814-H825. doi: 10.1152/ajpheart.00076.2018. Epub 2018 Jul 6.
4
Intramyocardial injection of a fully synthetic hydrogel attenuates left ventricular remodeling post myocardial infarction.
Biomaterials. 2019 Oct;217:119289. doi: 10.1016/j.biomaterials.2019.119289. Epub 2019 Jun 17.
7
The effect of hydrogel injection on cardiac function and myocardial mechanics in a computational post-infarction model.
Comput Methods Biomech Biomed Engin. 2013;16(11):1185-95. doi: 10.1080/10255842.2012.656611. Epub 2012 Mar 22.
8
Widely distributable and retainable in-situ gelling material for treating myocardial infarction.
Acta Biomater. 2024 Mar 1;176:221-233. doi: 10.1016/j.actbio.2024.01.013. Epub 2024 Jan 17.

引用本文的文献

2
Shear-Thinning Hydrogel for Delayed Delivery of a Small Molecule Metalloproteinase Inhibitor Attenuates Myocardial Infarction Remodeling.
JACC Basic Transl Sci. 2025 Apr;10(4):458-472. doi: 10.1016/j.jacbts.2024.11.009. Epub 2025 Jan 29.
5
Analysis of the mechanism of curcumin against osteoarthritis using metabolomics and transcriptomics.
Naunyn Schmiedebergs Arch Pharmacol. 2024 May;397(5):3313-3329. doi: 10.1007/s00210-023-02785-y. Epub 2023 Nov 8.
6
New treatment methods for myocardial infarction.
Front Cardiovasc Med. 2023 Sep 28;10:1251669. doi: 10.3389/fcvm.2023.1251669. eCollection 2023.
8
An Experimental and Numerical Investigation of Cardiac Tissue-Patch Interrelation.
J Biomech Eng. 2023 Aug 1;145(8). doi: 10.1115/1.4062736.
9
Therapeutic angiogenesis based on injectable hydrogel for protein delivery in ischemic heart disease.
iScience. 2023 Apr 10;26(5):106577. doi: 10.1016/j.isci.2023.106577. eCollection 2023 May 19.
10
Injectable selenium-containing polymeric hydrogel formulation for effective treatment of myocardial infarction.
Front Bioeng Biotechnol. 2022 Jul 11;10:912562. doi: 10.3389/fbioe.2022.912562. eCollection 2022.

本文引用的文献

1
MRI evaluation of injectable hyaluronic acid-based hydrogel therapy to limit ventricular remodeling after myocardial infarction.
Biomaterials. 2015 Nov;69:65-75. doi: 10.1016/j.biomaterials.2015.08.011. Epub 2015 Aug 6.
3
Timing underpins the benefits associated with injectable collagen biomaterial therapy for the treatment of myocardial infarction.
Biomaterials. 2015 Jan;39:182-92. doi: 10.1016/j.biomaterials.2014.11.004. Epub 2014 Nov 22.
5
Promotion of cardiac differentiation of brown adipose derived stem cells by chitosan hydrogel for repair after myocardial infarction.
Biomaterials. 2014 Apr;35(13):3986-98. doi: 10.1016/j.biomaterials.2014.01.021. Epub 2014 Feb 6.
6
Intramyocardial injection of a synthetic hydrogel with delivery of bFGF and IGF1 in a rat model of ischemic cardiomyopathy.
Biomacromolecules. 2014 Jan 13;15(1):1-11. doi: 10.1021/bm4010639. Epub 2014 Jan 2.
7
The effect of polymer degradation time on functional outcomes of temporary elastic patch support in ischemic cardiomyopathy.
Biomaterials. 2013 Oct;34(30):7353-63. doi: 10.1016/j.biomaterials.2013.06.020. Epub 2013 Jul 1.
8
Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction.
Sci Transl Med. 2013 Feb 20;5(173):173ra25. doi: 10.1126/scitranslmed.3005503.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验